Perkins Capital Management Inc Bristol Myers Squibb CO Transaction History

Perkins Capital Management Inc

$102 Million
Q3 2024

A detailed history of Perkins Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Perkins Capital Management Inc holds 14,491 shares of BMY stock, worth $851,780. This represents 0.74% of its overall portfolio holdings.

Number of Shares

14,491

Previous 16,991 14.71%

Holding current value

$851,780

Previous $705,000 6.24%

% of portfolio

0.74%

Previous 0.69%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$39.66 - $51.75 $99,149 - $129,375	-2,500 Reduced 14.71%	14,491 $749,000
Q2 2024 Aug 09, 2024	BUY	$40.25 - $52.99 $14,087 - $18,546	350 Added 2.1%	16,991 $705,000
Q4 2023 Jan 22, 2024	BUY	$48.48 - $57.85 $48,480 - $57,850	1,000 Added 6.39%	16,641 $854,000
Q3 2022 Oct 24, 2022	SELL	$0.13 - $76.84 $112 - $66,620	-867 Reduced 5.25%	15,641 $1.11 Million
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $3,110 - $3,626	58 Added 0.35%	16,508 $1.03 Million
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $17,322 - $19,629	-300 Reduced 1.79%	16,450 $1.02 Million
Q3 2020 Oct 28, 2020	SELL	$57.43 - $63.64 $7,178 - $7,955	-125 Reduced 0.74%	16,750 $1.01 Million
Q1 2020 Apr 29, 2020	SELL	$46.4 - $67.43 $13,920 - $20,229	-300 Reduced 1.75%	16,875 $941,000
Q4 2019 Feb 03, 2020	SELL	$49.21 - $64.19 $76,275 - $99,494	-1,550 Reduced 8.28%	17,175 $1.1 Million
Q3 2019 Oct 23, 2019	SELL	$42.77 - $50.71 $6,415 - $7,606	-150 Reduced 0.79%	18,725 $950,000
Q2 2019 Aug 09, 2019	BUY	$44.62 - $49.34 $267,720 - $296,040	6,000 Added 46.6%	18,875 $856,000
Q1 2019 Apr 22, 2019	SELL	$45.12 - $53.8 $146,640 - $174,850	-3,250 Reduced 20.16%	12,875 $614,000
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $115,805 - $150,171	-2,375 Reduced 12.84%	16,125 $838,000
Q3 2018 Oct 22, 2018	SELL	$55.19 - $62.25 $27,595 - $31,125	-500 Reduced 2.63%	18,500 $1.15 Million
Q2 2018 Aug 02, 2018	SELL	$50.53 - $62.98 $107,376 - $133,832	-2,125 Reduced 10.06%	19,000 $1.05 Million
Q1 2018 Apr 23, 2018	BUY	$59.92 - $68.98 $56,924 - $65,531	950 Added 4.71%	21,125 $1.34 Million
Q4 2017 Jan 26, 2018	BUY	$59.94 - $65.35 $158,841 - $173,177	2,650 Added 15.12%	20,175 $1.24 Million
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $967,905 - $1.12 Million	17,525	17,525 $1.12 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.

Account

Perkins Capital Management Inc Bristol Myers Squibb CO Transaction History